Published in Biotech Business Week, March 13th, 2006
DiaGenic ASA first announced findings from its pilot study in connection with the IPA's (International Psychogeriatric Association) 12th Congress on September 22, 2005. That study has now been reconfirmed with a larger study using Applied Biosystems microarray technology at the IMGM Laboratories in Germany.
"The results from the Alzheimer's study support DiaGenic's concept," said Are Aastveit, professor of Statistics, Norwegian University of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.